Spero Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ANSON FUNDS MANAGEMENT LP | 02/14/2025 | 3.84 M | $3.96 M | 2.38% | 7.09% |
PFIZER INC | 02/14/2025 | 2.36 M | $2.43 M | 100.00% | 4.36% |
VANGUARD GROUP INC | 02/11/2025 | 1.76 M | $1.82 M | 0.00% | 3.26% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 1.11 M | $1.14 M | 13.43% | 2.04% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 1.04 M | $1.07 M | -2.98% | 1.92% |
ALPHABET INC. | 02/07/2025 | 889,979 | $916,678 | 0.00% | 1.64% |
MURCHINSON LTD. | 02/14/2025 | 873,910 | $900,127 | 100.00% | 1.61% |
ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 801,277 | $825,315 | 7.78% | 1.48% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 485,352 | $499,912 | 0.11% | 0.90% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 481,128 | $495,703 | -0.01% | 0.89% |
02/10/2025 | 310,908 | $320,235 | 100.00% | 0.57% | |
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 02/06/2025 | 305,255 | $314,413 | -24.23% | 0.56% |
MACKENZIE FINANCIAL CORP | 02/20/2025 | 187,559 | $193,186 | 487.90% | 0.35% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 184,800 | $190,344 | 0.00% | 0.34% |
STATE STREET CORP | 02/14/2025 | 148,911 | $153,378 | 14.10% | 0.28% |
DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 125,000 | $128,750 | 0.00% | 0.23% |
JPMORGAN CHASE & CO | 02/12/2025 | 61,624 | $63,473 | 26,011.86% | 0.11% |
SQUAREPOINT OPS LLC | 02/14/2025 | 55,051 | $56,703 | 100.00% | 0.10% |
JANE STREET GROUP, LLC | 02/14/2025 | 52,869 | $54,455 | 100.00% | 0.10% |
PRUDENTIAL FINANCIAL INC | 02/11/2025 | 49,200 | $50,676 | 100.00% | 0.09% |
VIRTU FINANCIAL LLC | 02/11/2025 | 46,046 | $47,000 | 100.00% | 0.09% |
XTX TOPCO LTD | 02/13/2025 | 30,138 | $31,042 | 100.00% | 0.06% |
02/14/2025 | 30,000 | $30,900 | 100.00% | 0.06% | |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 29,755 | $30,648 | -32.71% | 0.06% |
DLK INVESTMENT MANAGEMENT, LLC | 01/16/2025 | 28,955 | $29,824 | -7.65% | 0.05% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 28,565 | $29,422 | 0.00% | 0.05% |
PFG INVESTMENTS, LLC | 01/22/2025 | 24,534 | $25,270 | 75.51% | 0.05% |
HRT FINANCIAL LP | 02/14/2025 | 14,692 | $15,000 | 100.00% | 0.03% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 10,003 | $10,303 | 0.00% | 0.02% |
NATIONAL BANK OF CANADA /FI/ | 02/12/2025 | 10,000 | $10,300 | 0.00% | 0.02% |
TEXAS YALE CAPITAL CORP. | 02/13/2025 | 10,000 | $10,300 | 100.00% | 0.02% |
US BANCORP \DE\ | 02/05/2025 | 5,151 | $5,306 | 3,311.26% | 0.01% |
SIMPLEX TRADING, LLC | 02/11/2025 | 5,110 | $5,000 | 454.83% | 0.01% |
FMR LLC | 02/13/2025 | 4,289 | $4,418 | 36.64% | 0.01% |
WR WEALTH PLANNERS, LLC | 02/05/2025 | 2,600 | $2,678 | 0.00% | 0.00% |
CULLEN/FROST BANKERS, INC. | 02/06/2025 | 2,000 | $2,060 | 0.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 929 | $957 | 245.35% | 0.00% |
ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 295 | $304 | 0.00% | 0.00% |
02/06/2025 | 213 | $219 | 100.00% | 0.00% | |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 200 | $206 | 0.00% | 0.00% |
RICHARDS, MERRILL & PETERSON, INC. | 02/13/2025 | 150 | $155 | 100.00% | 0.00% |
UBS GROUP AG | 02/14/2025 | 141 | $145 | -99.20% | 0.00% |
NEWEDGE ADVISORS, LLC | 02/13/2025 | 100 | $103 | 0.00% | 0.00% |
CORECAP ADVISORS, LLC | 02/14/2025 | 50 | $52 | -73.96% | 0.00% |
FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 02/14/2025 | 30 | $31 | 0.00% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 12 | $12 | 0.00% | 0.00% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
CIBC PRIVATE WEALTH GROUP, LLC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
NOVO HOLDINGS A/S | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Spero Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 67 institutional investors and hedge funds held shares of Spero Therapeutics, Inc.. The most heavily invested institutionals were:
Anson Funds Management LP: 3.84 M
PFIZER INC: 2.36 M
VANGUARD GROUP INC: 1.76 M
RENAISSANCE TECHNOLOGIES LLC: 1.11 M
ACADIAN ASSET MANAGEMENT LLC: 1.04 M
Alphabet Inc.: 889,979
28.97% of Spero Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 19.28 M shares in the last 24 months. This purchase volume represents approximately $16.02 M in transactions.